Cargando…

Design, validation and implementation of an automated e-alert for acute kidney injury: 6-month pilot study shows increased awareness

BACKGROUND: Acute kidney injury (AKI) is defined as a sudden episode of kidney failure but is known to be under-recognized by healthcare professionals. The Kidney Disease Improving Global Outcome (KDIGO) guidelines have formulated criteria to facilitate AKI diagnosis by comparing changes in plasma c...

Descripción completa

Detalles Bibliográficos
Autores principales: Niemantsverdriet, Michael S.A., Tiel Groenestege, Wouter M., Khairoun, M., Hoefer, Imo E., van Solinge, Wouter W., Bellomo, Domenico, van Vliet, Martin H., Kaasjager, Karin A.H., Haitjema, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375640/
https://www.ncbi.nlm.nih.gov/pubmed/37501175
http://dx.doi.org/10.1186/s12882-023-03265-4
Descripción
Sumario:BACKGROUND: Acute kidney injury (AKI) is defined as a sudden episode of kidney failure but is known to be under-recognized by healthcare professionals. The Kidney Disease Improving Global Outcome (KDIGO) guidelines have formulated criteria to facilitate AKI diagnosis by comparing changes in plasma creatinine measurements (PCr). To improve AKI awareness, we implemented these criteria as an electronic alert (e-alert), in our electronic health record (EHR) system. METHODS: For every new PCr measurement measured in the University Medical Center Utrecht that triggered the e-alert, we provided the physician with actionable insights in the form of a memo, to improve or stabilize kidney function. Since e-alerts qualify for software as a medical device (SaMD), we designed, implemented and validated the e-alert according to the European Union In Vitro Diagnostic Regulation (IVDR). RESULTS: We evaluated the impact of the e-alert using pilot data six months before and after implementation. 2,053 e-alerts of 866 patients were triggered in the before implementation, and 1,970 e-alerts of 853 patients were triggered after implementation. We found improvements in AKI awareness as measured by (1) 2 days PCr follow up (56.6–65.8%, p-value: 0.003), and (2) stop of nephrotoxic medication within 7 days of the e-alert (59.2–63.2%, p-value: 0.002). CONCLUSION: Here, we describe the design and implementation of the e-alert in line with the IVDR, leveraging a multi-disciplinary team consisting of physicians, clinical chemists, data managers and data scientists, and share our firsts results that indicate an improved awareness among treating physicians. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03265-4.